| Target Price | $765.00 |
| Price | $665.75 |
| Potential | 14.91% |
| Number of Estimates | 64 |
| 64 Analysts have issued a price target Meta Platforms (Facebook) 2027 . The average Meta Platforms (Facebook) target price is $765.00. This is 14.91% higher than the current stock price. The highest price target is $1,050.00 57.72% , the lowest is $585.80 12.01% . | |
| A rating was issued by 71 analysts: 62 Analysts recommend Meta Platforms (Facebook) to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Meta Platforms (Facebook) stock has an average upside potential 2027 of 14.91% . Most analysts recommend the Meta Platforms (Facebook) stock at Purchase. |
69 Analysts have issued a sales forecast Meta Platforms (Facebook) 2026 . The average Meta Platforms (Facebook) sales estimate is
This results in the following potential growth metrics:
55 Analysts have issued an Meta Platforms (Facebook) EBITDA forecast 2026. The average Meta Platforms (Facebook) EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
70 Meta Platforms (Facebook) Analysts have issued a net profit forecast 2026. The average Meta Platforms (Facebook) net profit estimate is
This results in the following potential growth metrics and future Net Margins:
70 Analysts have issued a Meta Platforms (Facebook) forecast for earnings per share. The average Meta Platforms (Facebook) EPS is
This results in the following potential growth metrics and future valuations:
Meta Platforms (Facebook)...
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Wedbush |
Neutral
➜
Neutral
|
Unchanged | Sep 14 2026 |
| JP Morgan |
Neutral
➜
Overweight
|
Upgrade | Sep 10 2026 |
| Wedbush |
Neutral
➜
Neutral
|
Unchanged | Sep 01 2026 |
| Rosenblatt |
Buy
➜
Buy
|
Unchanged | Aug 27 2026 |
| Needham |
Hold
➜
Hold
|
Unchanged | Aug 27 2026 |
| Truist Securities |
Buy
➜
Buy
|
Unchanged | Aug 27 2026 |
| Benchmark |
Hold
➜
Hold
|
Unchanged | Aug 27 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Wedbush:
Neutral
➜
Neutral
|
Sep 14 2026 |
|
Upgrade
JP Morgan:
Neutral
➜
Overweight
|
Sep 10 2026 |
|
Unchanged
Wedbush:
Neutral
➜
Neutral
|
Sep 01 2026 |
|
Unchanged
Rosenblatt:
Buy
➜
Buy
|
Aug 27 2026 |
|
Unchanged
Needham:
Hold
➜
Hold
|
Aug 27 2026 |
|
Unchanged
Truist Securities:
Buy
➜
Buy
|
Aug 27 2026 |
|
Unchanged
Benchmark:
Hold
➜
Hold
|
Aug 27 2026 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


